Figure 4From: Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas Serum anti-FLNC autoantibody levels and glioma progression. (A) Filamin C mRNA expression level inversely correlated with the serum anti-FLNC autoantibody concentrations (p = 0.0094, R = -0.433). (B) Serum anti-FLNC autoantibody levels were not difference between large tumors (size ≥3 cm) and small tumors (size <3 cm).Back to article page